跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-ATORVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-ATORVASTATIN
Authorized
STANDARD
PRIVA-ATORVASTATIN
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
50dc934b97df3245
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
50dc934b97df3245
Drug Approval Canada Name
PRIVA-ATORVASTATIN
Product Name
PRIVA-ATORVASTATIN
Status
Cancelled Post Market
Status Date
2022-07-29
Original Market Date
2019-10-22
Din
02482916
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA05 ATORVASTATIN
Atc Name
c 10 aa 05
Aig Number
0133055004
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
ATORVASTATIN (ATORVASTATIN CALCIUM)
80 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
50dc934b97df3245
Type
Standard
Back to Health Canada Approvals